Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1379102 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
Abstract
Starting from a potent pantolactone ketoamide cathepsin K inhibitor discovered from structural screening, conversion of the lactone scaffold to a pyrrolidine scaffold allowed exploration of the S3 subsite of cathepsin K. Manipulation of P3 and P1′P1′ groups afforded potent inhibitors with drug-like properties.
Graphical abstractStarting from a potent pantolactone ketoamide cathepsin K inhibitor derived from structural screening, conversion of the lactone scaffold to a pyrrolidine scaffold allowed exploration of the S3 subsite of cathepsin K. Manipulation of P3 and P1′P1′ groups afforded potent inhibitors with drug-like propertiesFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
David G. Barrett, John G. Catalano, David N. Deaton, Anne M. Hassell, Stacey T. Long, Aaron B. Miller, Larry R. Miller, John A. Ray, Vicente Samano, Lisa M. Shewchuk, Kevin J. Wells-Knecht, Derril H. Willard Jr., Lois L. Wright,